Plethysmographic variation index predicts fluid responsiveness in ventilated patients in the early phase of septic shock in the emergency department: a pilot study

J Crit Care. 2013 Oct;28(5):634-9. doi: 10.1016/j.jcrc.2013.03.011. Epub 2013 May 15.

Abstract

Purpose: Feasibility study examining whether plethysmographic variability index (PVI) can predict fluid responsiveness in mechanically ventilated patients in the early phase of septic shock in the emergency department.

Materials and methods: Monocentric, prospective, observational study that included 31 mechanically ventilated and sedated patients with septic shock in whom volume expansion was planned. The patients were equipped with a pulse oximeter that automatically calculated and displayed PVI. The intervention consisted in infusing 8 mL/kg of hydroxylethyl starch over a 20-minute period. Before and after intervention, we recorded PVI and measured the aortic velocity-time integral (VTIao) using transthoracic echocardiography. Responders were defined as patients who increased their VTIao by 15% or higher after fluid infusion.

Results: Sixteen patients were classified as responders, and 15 as nonresponders. Mean PVI values before intervention were significantly higher in responders vs nonresponders (30%±9% vs 8%±5%, P<.001). Plethysmographic variability index values before intervention were correlated with percent changes in VTIao induced by intervention (R2=0.67; P<.001). A PVI threshold value of 19% discriminates responders from nonresponders with a sensitivity of 94% and a specificity of 87% (area under the curve, 0.97; P<.001).

Conclusion: Our study suggests that PVI is a feasible and interesting method to predict fluid responsiveness in early phase septic shock patients in the emergency department.

Keywords: Fluid resuscitation; Heart-lung interactions; Mechanical ventilation; Plethysmographic variation index; Septic shock; Volume responsiveness.

MeSH terms

  • Aged
  • Blood Flow Velocity
  • Echocardiography
  • Emergency Service, Hospital*
  • Feasibility Studies
  • Female
  • Fluid Therapy*
  • Humans
  • Hydroxyethyl Starch Derivatives / therapeutic use
  • Male
  • Oximetry
  • Pilot Projects
  • Plasma Substitutes / therapeutic use
  • Plethysmography*
  • Prospective Studies
  • Respiration, Artificial*
  • Shock, Septic / physiopathology*
  • Shock, Septic / therapy*
  • Treatment Outcome

Substances

  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes